Sucralfate

CAS : 54182-58-0

Ref. 3D-OS05733

Informations sur le produit

• Nom: Sucralfate
• Synonymes: Sucrose octasulfate aluminium salt, Aluminium, hexadeca-μ-hydroxytetracosahydroxy[μ8-[1,3,4,6-tetra-O-sulfo-β-D-fructofuranosyl α-D-glucopyranoside tetrakis(hydrogen sulfato)(8-)]]hexadeca-, Aluminum, hexadeca-μ-hydroxytetracosahydroxy[μ₈-[[1,3,4,6-tetra-O-sulfo-β-<span class="text-smallcaps">D</smallcap>-fructofuranosyl α-<smallcap>D</span>-glucopyranoside tetrakis(sulfato-κO′)](8-)]]hexadeca-, Antepsin, Carafate, Citogel, Hexadeca-μ-hydroxytetracosahydroxy[μ₈-[[1,3,4,6-tetra-O-sulfo-β-<span class="text-smallcaps">D</smallcap>-fructofuranosyl α-<smallcap>D</span>-glucopyranoside tetrakis(sulfato-κO′)](8-)]]hexadecaaluminum, Hexagastron, Keal, Succosa, Sucralafate, Sucralfat, Sucralfato, Sucralfin, Sucrate, Sugast, Sulcrate, Ulcar, Ulcerlmin, Ulcermin, Ulcogant, Urbal, Venter
• CAS: 54182-58-0

Description

Sucralfate is a drug that is used to treat and prevent injury-related inflammation by forming a protective barrier on the lining of the stomach and duodenum. Sucralfate has been shown to be effective in the treatment of infectious diseases, such as viral or bacterial infections, and also for radiation enteritis and ulcerative colitis. Sucralfate may interfere with the absorption of other drugs, such as acyclic nucleoside phosphonates, which are used to treat HIV/AIDS. This drug has also been shown to have anti-inflammatory properties through inhibition of prostaglandin synthesis. Sucralfate has been shown to have anti-inflammatory properties through inhibition of prostaglandin synthesis.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 2,086.74 g/mol
• Formule: C₁₂H₅₄Al₁₆O₇₅S₈
• Couleur/Forme: White Off-White Powder